The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 27, 2015

Filed:

Dec. 07, 2009
Applicants:

Thuy-anh Tran, San Diego, CA (US);

Rena Hayashi, Hacienda Heights, CA (US);

Jason B. Ibarra, Las Vegas, NV (US);

Brett Ullman, San Diego, CA (US);

Ning Zou, San Diego, CA (US);

Inventors:

Thuy-Anh Tran, San Diego, CA (US);

Rena Hayashi, Hacienda Heights, CA (US);

Jason B. Ibarra, Las Vegas, NV (US);

Brett Ullman, San Diego, CA (US);

Ning Zou, San Diego, CA (US);

Assignee:

Arena Pharmaceuticals, Inc., San Diego, CA (US);

Attorney:
Int. Cl.
CPC ...
C07D 253/07 (2006.01); C07D 401/04 (2006.01); C07D 403/04 (2006.01); A61K 31/53 (2006.01); A61K 31/4427 (2006.01); A61P 9/12 (2006.01); A61P 11/08 (2006.01); C07D 409/04 (2006.01); C07D 237/14 (2006.01); A61K 31/50 (2006.01); A61K 31/501 (2006.01);
U.S. Cl.
CPC ...
C07D 237/14 (2013.01); C07D 253/07 (2013.01); C07D 401/04 (2013.01); C07D 403/04 (2013.01); C07D 409/04 (2013.01);
Abstract

Cyclohexane derivatives of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pulmonary arterial hypertension (PAH) and related disorders; platelet aggregation; coronary artery disease; myocardial infarction; transient ischemic attack; angina; stroke; ischemia-reperfusion injury; restenosis; atrial fibrillation; blood clot formation in an angioplasty or coronary bypass surgery individual or in an individual suffering from atrial fibrillation; atherosclerosis; atherothrombosis; asthma or a symptom thereof; a diabetic-related disorder such as diabetic peripheral neuropathy, diabetic nephropathy or diabetic retinopathy; glaucoma or other disease of the eye with abnormal intraocular pressure; hypertension; inflammation; psoriasis; psoriatic arthritis; rheumatoid arthritis; Crohn's disease; transplant rejection; multiple sclerosis; systemic lupus erythematosus (SLE); ulcerative colitis; ischemia-reperfusion injury; restenosis; atherosclerosis; acne; type 1 diabetes; type 2 diabetes; sepsis; and chronic obstructive pulmonary disorder (COPD).


Find Patent Forward Citations

Loading…